By proceeding, you agree to our Terms of Use and Privacy Policy.
Radiopharm Theranostics is developing a world-class platform of radiopharmaceutical and nuclear medicine products for both diagnostic and therapeutic uses.
26-28 July 2022
With two prostate cancer-focused approvals in the last year, RLT is finally getting the attention it deserves from investors, biotech, and the wider oncology field. Though still the 3rd line of exotic therapy, the ever-growing pipeline of therapeutic
Event Ended
USA
Paid
Boston
25-27 July 2023
The 2nd Annual Targeted Radiopharmaceuticals Summit US is set to take place, highlighting the industry's progress and growth as more compounds are moving through clinical trials. This event is the only industry-led meeting dedicated to accelerating T